Thom Rasche

Healthcare #healthcare executive with more than 30 years experience in operating and investing in companies. #VC Partner @EarlybirdVC

[Earlybird VC @EarlybirdVC]

2022 was memorable! 🎢

We ran the numbers 📊 :
82 investments 💸
81 people on teams 👋
33 Earlybird's View articles ✍️
3 Unicorns🦄
2 new offices 📍
1 mission to support European startups! ❤️‍🔥

👀 Year in Review w/ highlights across the family of funds: https://t.co/SVeX5d0uma

[iSTAR Medical @iSTARMed]

We’ve entered into a strategic alliance with @abbvie. iSTAR Medical will receive a $60M non-dilutive upfront payment and AbbVie will hold the exclusive right to acquire iSTAR Medical at their discretion.

More: https://t.co/CZWUFpXUMi

#MIGS #MINIject #Glaucoma

[Earlybird VC @EarlybirdVC]

🧬 Got a strong background in STEM?
🔬 Keen to explore a Career Beyond the Bench?
🔎 See more & apply for our Earlybird Health Fellowship https://t.co/S5i58LZIaS

#hiring #healthcare #investing #fellowship #EBVCteam

@raschethom @hampshireUK @ChrisMassner @NasrallahRabab

[Earlybird VC @EarlybirdVC]

Don't miss out on 5️⃣ key insights by Earlybird Health's @ChrisMassner on how #psychedelics could revolutionize #mentalhealth #treatment & why #VCs are investing in its research.

👀 a new Medium article👉🏽 https://t.co/jcwfz91re7

w/ @raschethom, @NasrallahRabab & @ElishevaMarcus

[Thom Rasche @raschethom]

@BVMed Thanks to @BVMed Academie for hosting this #MedTech Innovation Hall!

My advice to young companies seeking to integrate AI into #healthcare: consider the complexity of human beings; AI is a tool, not a replacement.

⬇️ Don't miss out on more insights from the session.

[BVMed @BVMed]

Passen #KI-Medizinprodukte, #AIA und #EUMDR zusammen? Noch nicht ganz. Regulierungen müssen harmonisiert und die MDR KI-tauglich gestaltet werden, so die Expert:innen der Innovation Hall. Die KI-Vorteile in der Medizin zeigten sie mit Praxisbeispielen auf. https://t.co/4XOutqH0eo

[Earlybird VC @EarlybirdVC]

✍️New article in a Digital Health series: Maresa of Earlybird Digital West dives into the state of European #DigitalHealth Investments.

She covers #VC activity & distribution across stages + countries. Discover her data-driven forecasts.

👀 👉🏽 https://t.co/86fe5eoj9j

#EBVCblog

[Catherine F. @Catherine_Efe]

For anyone trying to get into the VC space, this article is a must read 👇🏾cc:@ElishevaMarcus

[iSTAR Medical @iSTARMed]

At the #DOC2022, Prof. Dr med. Marc Schargus will present a meta-analysis from the STAR-I, II, III, trials on patients with open-angle #glaucoma implanted with #MINIject.

More here: https://t.co/ckN6Cy3Vbh

#MIGS

[Thom Rasche @raschethom]

There is no doubt: #Digital #Health investing is interesting and ambitious at the same time. How does it differ from #MedTech #investing?
➡️ Find my answer in this @MedTechStrat #article by @DCassak: https://t.co/5IH0d65uXw

[Earlybird VC @EarlybirdVC]

🇨🇭@TechTourHQ Health 2022 is returning for a 13th edition to Lausanne, #Switzerland.

🤝 Build long-lasting relationships with international #investors & #entrepreneurs in the #HealthTech field.

🗓June 21-22: Meet @ChrisMassner from Earlybird Health!

👉🏽 https://t.co/LofQwzkxUT

[iSTAR Medical @iSTARMed]

Did you catch us at #EGS2022? The iSTAR Medical team thoroughly enjoyed the @EGUS_org congress in Athens.

Find out more here: https://t.co/ryGroWgCjq

#MIGS #Ophthalmology #MINIject

[Natalie Gladkov @BVMed_Digital]

„Viele [Startups] lernen gerade, dass es weniger um die Technologie und mehr um die Einführung eines Produkts in einen hochregulierten Gesundheitsmarkt geht“, so Thom Rasche @EarlybirdVC im @handelsblatt unter: https://t.co/Rs7zHaCeTe

[Earlybird VC @EarlybirdVC]

"Many [startups] are just learning that it's less about the technology & more about launching a #product into a highly regulated #healthcare market." - @raschethom Partner, Earlybird Health

👀 @NasrallahRabab @ChrisMassner @LionelCarnot @hampshireUK @rolfmathies @ElishevaMarcus

[Earlybird VC @EarlybirdVC]

🔬 Earlybird Health welcomes 🇫🇷@ImcheckThx to the #EBVCgang!

ImCheck develops nextgen immunotherapeutic antibodies targeting gamma-delta T cells for treating solid & hematological #cancers, infectious & autoimmune #diseases.

👀 Series C 📰@FierceBiotech https://t.co/jAWPlKbeCN

[iSTAR Medical @iSTARMed]

We presented a meta-analysis from 3 international clinical trials for #MINIject, the only commercially available supraciliary #MIGS device, at the 15th @EUGS_org Congress in Athens.

More here: https://t.co/iSebh97Bo5

#EGS2022

[Earlybird VC @EarlybirdVC]

📣 Beyond the Bench Seminar by @MGPA & @harvardmed’s @MassGeneralNews is your #chance to discover #opportunities #beyondacademia.

Join #healthcare #investing experts incl @NasrallahRabab of Earlybird Health

📍Thurs, 9 June 11:30pm CET/ 5:30pm EDT
👉🏽 Zoom https://t.co/xUj6WIfnv0

[Bits & Pretzels @bitsandpretzels]

Hear from these speakers & many more on the 29-30 June 2022, at the first annual Bits & Pretzels HealthTech Conference hosted at ICM Munich.🎉

85% of our tickets have already sold out so the time to buy yours is now!🎟️

Link: https://t.co/GShcg3JVWD

#bitshealth #bitsandpretzels

[Earlybird VC @EarlybirdVC]

A @Jefferies survey explored impact of funding on R&D budgets:

How will they change in new funding environments? What's the mindset of experienced #biotech investors?

Join a call w/ Earlybird Health's @LionelCarnot to learn more!

📍Tue May 24 10am ET
👉🏽https://t.co/lrnkDiSgdY

[Earlybird VC @EarlybirdVC]

“Oviva is one of the few #digitalcare delivery #startups operating in multiple European countries while being reimbursed by different (#healthcare) systems,”

Our Principal @ChrisMassner on Earlybird Health's @OvivaHealth listed in @BusinessInsider 📰

👀 https://t.co/kPV910nZKo